ICD-10-CM/PCS MS-DRG v39.1 Definitions Manual |
||||
Skip to content |
MDC 16 Diseases and disorders of blood, blood forming organs and immunologic disorders |
Red blood cell disorders |
MCC | DRG |
---|---|
Yes | 811 |
No | 812 |
DRG 811 RED BLOOD CELL DISORDERS WITH MCC
DRG 812 RED BLOOD CELL DISORDERS WITHOUT MCC
PRINCIPAL DIAGNOSIS
D460 | Refractory anemia without ring sideroblasts, so stated |
D461 | Refractory anemia with ring sideroblasts |
D4620 | Refractory anemia with excess of blasts, unspecified |
D4621 | Refractory anemia with excess of blasts 1 |
D4622 | Refractory anemia with excess of blasts 2 |
D464 | Refractory anemia, unspecified |
D469 | Myelodysplastic syndrome, unspecified |
D46A | Refractory cytopenia with multilineage dysplasia |
D46B | Refractory cytopenia with multilineage dysplasia and ring sideroblasts |
D46C | Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality |
D46Z | Other myelodysplastic syndromes |
D500 | Iron deficiency anemia secondary to blood loss (chronic) |
D501 | Sideropenic dysphagia |
D508 | Other iron deficiency anemias |
D509 | Iron deficiency anemia, unspecified |
D510 | Vitamin B12 deficiency anemia due to intrinsic factor deficiency |
D511 | Vitamin B12 deficiency anemia due to selective vitamin B12 malabsorption with proteinuria |
D512 | Transcobalamin II deficiency |
D513 | Other dietary vitamin B12 deficiency anemia |
D518 | Other vitamin B12 deficiency anemias |
D519 | Vitamin B12 deficiency anemia, unspecified |
D520 | Dietary folate deficiency anemia |
D521 | Drug-induced folate deficiency anemia |
D528 | Other folate deficiency anemias |
D529 | Folate deficiency anemia, unspecified |
D530 | Protein deficiency anemia |
D531 | Other megaloblastic anemias, not elsewhere classified |
D532 | Scorbutic anemia |
D538 | Other specified nutritional anemias |
D539 | Nutritional anemia, unspecified |
D550 | Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency |
D551 | Anemia due to other disorders of glutathione metabolism |
D5521 | Anemia due to pyruvate kinase deficiency |
D5529 | Anemia due to other disorders of glycolytic enzymes |
D553 | Anemia due to disorders of nucleotide metabolism |
D558 | Other anemias due to enzyme disorders |
D559 | Anemia due to enzyme disorder, unspecified |
D560 | Alpha thalassemia |
D561 | Beta thalassemia |
D562 | Delta-beta thalassemia |
D563 | Thalassemia minor |
D564 | Hereditary persistence of fetal hemoglobin [HPFH] |
D565 | Hemoglobin E-beta thalassemia |
D568 | Other thalassemias |
D569 | Thalassemia, unspecified |
D5700 | Hb-SS disease with crisis, unspecified |
D5701 | Hb-SS disease with acute chest syndrome |
D5702 | Hb-SS disease with splenic sequestration |
D5703 | Hb-SS disease with cerebral vascular involvement |
D5709 | Hb-SS disease with crisis with other specified complication |
D571 | Sickle-cell disease without crisis |
D5720 | Sickle-cell/Hb-C disease without crisis |
D57211 | Sickle-cell/Hb-C disease with acute chest syndrome |
D57212 | Sickle-cell/Hb-C disease with splenic sequestration |
D57213 | Sickle-cell/Hb-C disease with cerebral vascular involvement |
D57218 | Sickle-cell/Hb-C disease with crisis with other specified complication |
D57219 | Sickle-cell/Hb-C disease with crisis, unspecified |
D573 | Sickle-cell trait |
D5740 | Sickle-cell thalassemia without crisis |
D57411 | Sickle-cell thalassemia, unspecified, with acute chest syndrome |
D57412 | Sickle-cell thalassemia, unspecified, with splenic sequestration |
D57413 | Sickle-cell thalassemia, unspecified, with cerebral vascular involvement |
D57418 | Sickle-cell thalassemia, unspecified, with crisis with other specified complication |
D57419 | Sickle-cell thalassemia, unspecified, with crisis |
D5742 | Sickle-cell thalassemia beta zero without crisis |
D57431 | Sickle-cell thalassemia beta zero with acute chest syndrome |
D57432 | Sickle-cell thalassemia beta zero with splenic sequestration |
D57433 | Sickle-cell thalassemia beta zero with cerebral vascular involvement |
D57438 | Sickle-cell thalassemia beta zero with crisis with other specified complication |
D57439 | Sickle-cell thalassemia beta zero with crisis, unspecified |
D5744 | Sickle-cell thalassemia beta plus without crisis |
D57451 | Sickle-cell thalassemia beta plus with acute chest syndrome |
D57452 | Sickle-cell thalassemia beta plus with splenic sequestration |
D57453 | Sickle-cell thalassemia beta plus with cerebral vascular involvement |
D57458 | Sickle-cell thalassemia beta plus with crisis with other specified complication |
D57459 | Sickle-cell thalassemia beta plus with crisis, unspecified |
D5780 | Other sickle-cell disorders without crisis |
D57811 | Other sickle-cell disorders with acute chest syndrome |
D57812 | Other sickle-cell disorders with splenic sequestration |
D57813 | Other sickle-cell disorders with cerebral vascular involvement |
D57818 | Other sickle-cell disorders with crisis with other specified complication |
D57819 | Other sickle-cell disorders with crisis, unspecified |
D580 | Hereditary spherocytosis |
D581 | Hereditary elliptocytosis |
D582 | Other hemoglobinopathies |
D588 | Other specified hereditary hemolytic anemias |
D589 | Hereditary hemolytic anemia, unspecified |
D593 | Hemolytic-uremic syndrome |
D62 | Acute posthemorrhagic anemia |
D630 | Anemia in neoplastic disease |
D631 | Anemia in chronic kidney disease |
D638 | Anemia in other chronic diseases classified elsewhere |
D640 | Hereditary sideroblastic anemia |
D641 | Secondary sideroblastic anemia due to disease |
D642 | Secondary sideroblastic anemia due to drugs and toxins |
D643 | Other sideroblastic anemias |
D644 | Congenital dyserythropoietic anemia |
D6481 | Anemia due to antineoplastic chemotherapy |
D6489 | Other specified anemias |
D649 | Anemia, unspecified |
D740 | Congenital methemoglobinemia |
D748 | Other methemoglobinemias |
D749 | Methemoglobinemia, unspecified |
R710 | Precipitous drop in hematocrit |
R718 | Other abnormality of red blood cells |
T8030XA | ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter |
T80310A | ABO incompatibility with acute hemolytic transfusion reaction, initial encounter |
T80311A | ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter |
T80319A | ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter |
T8039XA | Other ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter |
T8040XA | Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter |
T80410A | Rh incompatibility with acute hemolytic transfusion reaction, initial encounter |
T80411A | Rh incompatibility with delayed hemolytic transfusion reaction, initial encounter |
T80419A | Rh incompatibility with hemolytic transfusion reaction, unspecified, initial encounter |
T8049XA | Other Rh incompatibility reaction due to transfusion of blood or blood products, initial encounter |
T8089XA | Other complications following infusion, transfusion and therapeutic injection, initial encounter |
T80910A | Acute hemolytic transfusion reaction, unspecified incompatibility, initial encounter |
T80911A | Delayed hemolytic transfusion reaction, unspecified incompatibility, initial encounter |
T80919A | Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, initial encounter |
T8092XA | Unspecified transfusion reaction, initial encounter |
T80A0XA | Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter |
T80A10A | Non-ABO incompatibility with acute hemolytic transfusion reaction, initial encounter |
T80A11A | Non-ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter |
T80A19A | Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter |
T80A9XA | Other non-ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter |
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 16 Mar 2022 16:20:17 CMS, code-revision=332, description-revision=1327 |